arznei-telegramm Logo a-t Kurzlogo
    ❮ a-t 8/2025 a-t ❯
    This is a translation of the table of contents. One article of each issue is translated and freely available.
    table of contents
    NEW ON THE MARKET

    Rimegepant (VYDURA) for the treatment of acute migraine

    Bevacizumab gamma (LYTENAVA) for wet macular degeneration

    a-t READERS QUESTIONS AND COMMENTS

    Coenzym Q10 in statin-treated patients – what's new?

    IN BRIEF

    Respiratory syncytial virus vaccination with the mRNA vaccine mRESVIA?

    Atrial fibrillation: when to start with anticoagulation after stroke?

    New flu vaccines for the 2024-2025 season

    Structured exercise after adjuvant chemotherapy for colon cancer

    Where the money goes: drugs with the highest turnover 2024-2025

    SIDE EFFECTS

    Caution: hypercalcaemia due to antacids in pregnancy

    Lasting damage caused by lash extensions, eyeliner tattoos and other procedures
    free

    e a-t ON THE INTERNET

    Bevacizumab gamma (LYTENAVA) for wet macular degeneration (long version)

    Atrial fibrillation: when to start with anticoagulation after stroke? (long version)

    arznei-telegramm

    Independent drug information – in English

    Concise, critical evaluations of drugs and medical devices for evidence-based therapy and patient advice on benefits and risks – independent, ad-free and funded exclusively by subscriptions.

    Browse free articles

    Wir schätzen Ihr Feedback

    Nehmen Sie an unserer Umfrage teil!